CHARLOTTE ALLERTON
Board of Directors member
Charlotte Allerton, SVP, Head of Preclinical and Translational Sciences, is responsible for working across Pfizer’s therapeutic areas from discovery to patients, leading modality design, translational clinical and non-clinical sciences, drug safety, and pharmaceutical sciences. Additionally, she serves as the Kendall Square Site Head in Cambridge, MA.
Charlotte joined Pfizer as a medicinal chemist, and has gone on to hold numerous leadership positions, including Head of Medicine Design, Chief Scientific Officer for Anti-Infectives and Head of Discovery and Early Development. In these roles, Charlotte was responsible for the advancement of multiple therapies from research through to clinical proof of concept. Notably, Charlotte co-led the discovery and development of Paxlovid, an antiviral therapy that continues to play a significant role in the treatment of COVID-19 and earned the prestigious Prix Galien Award and ACS Heroes of Chemistry Award.
Charlotte's contributions to the field have been recognized. She is an honorary fellow of the Royal Society of Chemistry. In 2020, she was celebrated as one of the Fiercest Women in Life Sciences and received the Healthcare Businesswomen's Association Luminary award for her advocacy in advancing women in the healthcare industry. In 2024 she was recognized on the Medicine Maker Power List. Charlotte sits on the Board of Directors of ViiV Healthcare. Charlotte earned a Bachelor of Science degree from the University of Nottingham and a Master of Philosophy in organic chemistry from the University of Cambridge.
YOU MAY ALSO BE INTERESTED IN
Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.
Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.
NP-GBL-HVX-COCO-220025 September 2025
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
